Five key IP takeaways from Pfizer’s $11.6 billion Biohaven buyout
The industry's biggest deal of 2022 focuses on a small number of patent-protected assets
The industry's biggest deal of 2022 focuses on a small number of patent-protected assets
The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend
Korean automaker adds portfolios from Intel and IBM as it continues to show interest in UAV and natural language processing tech
Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape
18 May 2022
Elon Musk will have to make certain that IP vital to the company’s future cannot just walk out the door
06 May 2022
WiLAN boss’s untimely death announced by firm’s parent company Quarterhill
05 May 2022
Chinese handset vendor taps portfolio of former litigation opponent as disputes with Nokia and InterDigital heat up
05 May 2022
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
04 May 2022
After getting a chance to hear from the US president’s pick to lead the USPTO, respondents to IAM’s insight panel swung from negative to neutral
02 May 2022
While the respective IP laws of ASEAN states differ with regard to data exclusivity in the field of life sciences, all are focused on strengthening the enforcement of IP rights for pharmaceutical products.
27 April 2022
The respective IP laws of ASEAN states differ when it comes to IP ownership and sharing provisions.
20 April 2022
Entity assigned more than 100 patents by the Korean tech giant is run by previous chief of Samsung’s semiconductor IP division
19 April 2022
Sierra Oncology buyout is motivated by previously unwanted drug asset it bought for a $3 million upfront fee
15 April 2022
Get unlimited access to all IAM content